The pediatric cardiology pharmacopeia: 2013 Update

Paul Nicholas Severin*, Sawsan Awad, Beth Shields, Joan Hoffman, William Bonney, Edmundo Cortez, Rani Ganesan, Aloka Patel, Steve Barnes, Sean Barnes, Shada Al-Anani, Umang Gupta, Yolandee Bell Cheddar, Ismael E. Gonzalez, Kiran Mallula, Hani Ghawi, Suhaib Kazmouz, Salwa Gendi, Raid Abdulla

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


The use of medications plays a pivotal role in the management of children with heart diseases. Most children with increased pulmonary blood flow require chronic use of anticongestive heart failure medications until more definitive interventional or surgical procedures are performed. The use of such medications, particularly inotropic agents and diuretics, is even more amplified during the postoperative period. Currently, children are undergoing surgical intervention at an ever younger age with excellent results aided by advanced anesthetic and postoperative care. The most significant of these advanced measures includes invasive and noninvasive monitoring as well as a wide array of pharmacologic agents. This review update provides a medication guide for medical practitioners involved in care of children with heart diseases.

Original languageEnglish (US)
Pages (from-to)1-29
Number of pages29
JournalPediatric cardiology
Issue number1
StatePublished - Jan 2013


  • Antiarrhythmic
  • Anticoagulants
  • Congestive heart failure
  • Diuretics
  • Fetal drugs
  • Inotropes
  • Pediatric cardiology
  • Pharmacologic agents
  • Pharmacopeia
  • Vasodilators

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'The pediatric cardiology pharmacopeia: 2013 Update'. Together they form a unique fingerprint.

Cite this